+919998510543
Downloads
Online IPO
Online KYC
e-KYC
+919998510543
Back Office Login
Live Trading
Send "Hi" to get your Back Office details.
Click Here -
https://wa.me/+919998510543
x
Home
About Us
Market
Equity
IPO
Derivatives
Currency Derivative
Authorised Person
Install Dealer Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
List of AP
Client
Install Solo Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
Install ACMP PRO Android Mobile App
Install ACMP PRO iPhone Mobile App
COLLATERAL INFORMATION
6 KYC Updation
NSDL E-VOTING
CDSL E-Voting
NSDL Nomination Online
NSDL e-Services
NSDL – Online Account Closure cum Transfer Request
ACML Announcement
Event
communique
Announcement
Contact us
CAREERS
Home
About Us
Market
Equity
IPO
Derivatives
Currency Derivative
Authorised Person
Install Dealer Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
List of AP
Client
Install Solo Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
Install ACMP PRO Android Mobile App
Install ACMP PRO iPhone Mobile App
COLLATERAL INFORMATION
6 KYC Updation
NSDL E-VOTING
CDSL E-Voting
NSDL Nomination Online
Announcement
communique
Announcement
Contact us
CAREERS
IPO
Home
IPO
IPO Synopsis
Forthcoming IPO
Open IPO
Close IPO
New Listing
Basis of Allotment
Draft Prospectus
New Issue Monitor
IPO Synopsis
Rossari Biotech Ltd
Registered Office:
201 A-B 2nd Floor LBS Marg,Akruti Corporate Park Kanjur(W , Mumbai - 400079 , Maharashtra , India.
Phone : 91-22-6123 3800 Fax:91-22-2579 6982
Email :
cs@rossarimail.com
Website :
www.rossari.com
Initial Public Offering of 11,676,470 equity shares of face value of Rs. 2 each ("equity shares") of Rossari Biotech Limited (the "company" or the "issuer") for cash at a price of Rs. 425 per equity share (including a share premium of Rs. 423 per equity share) (the "offer price") aggregating to Rs. 496.25 Crores comprising a fresh issue of 1,176,470 equity shares aggregating to Rs. 50* Crores (the "fresh issue") and an offer for sale of 10,500,000 equity shares (the "offered shares") aggregating to Rs. 44.63 Crores, comprising an offer for sale of 5,250,000 equity shares aggregating to Rs. 22.31 Crores by Mr. Edward Menezes and 5,250,000 equity shares aggregating to Rs. 22.31 Crores by Mr. Sunil Chari (the "promoter selling shareholders" or the "selling shareholders"), (the "offer for sale", and together with the fresh issue, the "offer"). The offer shall constitute 22.49% of the post-offer paid up equity share capital of the company. The company has, in consultation with the book running lead managers ("brlms"), undertaken a private placement of equity shares aggregating to Rs. 99.999 Crores ("pre-ipo placement"). The size of the fresh issue of up to Rs. 150 Crores has been reduced by Rs. 99.999 Crores pursuant to the pre-ipo placement and accordingly, the size of the fresh issue is up to Rs. 50. Crores
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
13-Jul-20
15-Jul-20
R
s
425.00-0.00
R
s
0.00-0.00
Minimum Application for shares in Nos :35 Further Multiples of :35
R
s
Cr
Lead Managers to the Issue
Project Cost
0.00
Axis Capital Ltd
Project Financed through Current Offer
496.25
Post Issue Equity Share Capital
10.39
Issue Price
R
s
425.00
Projects
Repayment/Prepayment of certain Indebtedness availed by the company (including accrued Interest)
General Corporate Purposes
Funding Working Capital Requirements
Promoted By
Edward Walter Menezes
Sunil Srinivasan Chari
Listing At
BSE
NSE
Registrar to the Issue
Link Intime India Pvt Ltd